US Edition
Published • loading... • Updated
Exclusive: US Nicotine Pouch Fast-Track Scheme Slowed by Worries over Youth, New Users
Agency reviewers are weighing whether the products help smokers switch without increasing addiction among children and non-users, sources said.
- The U.S. Food and Drug Administration has delayed fast-track approvals for new nicotine pouch brands, citing concerns regarding potential addiction risks to youth and other non-smokers.
- Originally, the agency planned to expedite these applications through a pilot program, but reviewers now state the scientific evidence for speeding them through was 'not as clear' as expected.
- Nicotine pouches represent the fastest-growing product segment in the United States, with millions of users and a market worth some $22 billion.
- Tobacco stocks faced significant volatility on Wednesday, as Turning Point Brands shares plunged over 17% and Philip Morris International stock fell more than 7% following the reports.
- Regulators now face a complex balancing act, weighing the potential benefits of pouches as smoking cessation tools against growing concerns that increased accessibility could drive nicotine addiction among children and young adults.
Insights by Ground AI
23 Articles
23 Articles
Helena Independent Record+15 Reposted by 15 other sources
Fast-track plan for nicotine pouches in US slowed by worries over youth, new users
When granting licenses, the FDA weighs whether products can help smokers switch to a less harmful form of nicotine while not driving risks too high for non-tobacco users and children.
·Helena, United States
Read Full Article
Coverage Details
Total News Sources23
Leaning Left2Leaning Right3Center17Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
C 77%
14%
Factuality
To view factuality data please Upgrade to Premium
